Biotechnology · Immunology & Inflammation Therapeutics
Abivax |: Risk & public record
Abivax |: 33 research papers in five years.
Data updated Nov 20, 2026 · Back to the company report
What the registers and the postings say about this employer.
Legal entity active
ABIVAX · annuaire-entreprises.data.gouv.fr ↗
Yes
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Public record
Abivax |: 33 research papers in five years.
Research outputpapers its people wrote, per OpenAlex
33papers in five years
952citations
Inflammatory Bowel Disease
Medicine
55 papers
Microscopic Colitis
Medicine
37 papers
Ocular Diseases and Behçet’s Syndrome
Medicine
34 papers
Rheumatoid Arthritis Research and Therapies
Medicine
28 papers
HIV Research and Treatment
Immunology and Microbiology
12 papers
Patents
Published US applications
35
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.
